FBIOP
Fortress Biotech, Inc.
Key Financials
Net Income
$6.8M
↑ 114.8%
Gross Profit
$3.5M
N/A
Revenue
$63.3M
↑ 9.7%
Operating Income
$-70221000
↑ 36.4%
EPS (Diluted)
$-0.07
↑ 97.4%
Shareholders' Equity
$49.9M
↑ 119.3%
Total Assets
$185.5M
↑ 28.7%
Total Liabilities
$123.4M
↓ 15.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/1/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
| SCHEDULE 13D/A | 3/20/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 4 | 3/20/2026 | View on SEC |
| 8-K | 2/23/2026 | View on SEC |
| 8-K | 1/13/2026 | View on SEC |
| SCHEDULE 13D/A | 1/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FBIOP |
| Company Name | Fortress Biotech, Inc. |
| CIK | 1429260 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-652-4500 |